FDA Denies Approval of Generic OxyContin

On April 16, 2013, the Food & Drug Administration announced that it will not be approving generic OxyContin, the same day the patent expired for the abuse resistant type.  The FDA action appears in line with national concern over the meteoric rise in opiates use...